BGB-A333, an anti-PD-L1 monoclonal antibody, in combination with tislelizumab in patients with urothelial carcinoma

J. Martin Liberal, P. C. Fong, V. Moreno, S. Frentzas, J. Desai, T. Meniawy, B. Markman, M. Voskoboynik, N. Budha, J. Wu, W. Shen, M. Singh, E. Calvo

Research output: Contribution to journalAbstract/Meeting Abstractpeer-review

1 Citation (Web of Science)
Original languageEnglish
Pages (from-to)S468-S469
Number of pages2
JournalAnnals of Oncology
Publication statusPublished - Sept 2020
Externally publishedYes
EventESMO Virtual Congress -
Duration: 19 Sept 202018 Oct 2020

Cite this